A nurse is caring for a client experiencing alcohol withdrawal who has been prescribed chlordiazepoxide (Librium). Which assessment finding would require the nurse to hold the medication and notify the healthcare provider immediately?

Respiratory rate of 8 breaths/min indicates severe respiratory depression, a critical adverse effect of benzodiazepines requiring immediate medication hold and provider notification. Other findings (elevated BP, tremors, anxiety) are expected in alcohol withdrawal and do not necessitate stopping the medication.

Understanding the Priority Assessment
The question asks you to identify the finding that requires immediately holding chlordiazepoxide and notifying the provider. This is a priority-setting question testing your ability to recognize a life-threatening adverse effect. Chlordiazepoxide is a long-acting benzodiazepine that enhances the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). While effective for reducing the hyperautonomic state of alcohol withdrawal, its mechanism directly causes central nervous system depression. The most dangerous extension of this therapeutic effect is profound sedation and respiratory depression.

Analyzing the Correct Answer
Respiratory rate 8 breaths per minute is the critical finding.
A respiratory rate this low indicates severe respiratory depression, a known life-threatening adverse effect of benzodiazepines. The research by Reiter et al. confirms that chlordiazepoxide use for alcohol withdrawal is associated with a risk of sedation leading to respiratory depression, which can be severe enough to necessitate intensive care unit (ICU) admission and mechanical ventilation ^[1]. This risk is heightened by the drug's pharmacokinetic profile; chlordiazepoxide has active metabolites with long half-lives, which can lead to drug accumulation and prolonged, unpredictable sedation, particularly in vulnerable patients ^[2]. The nurse’s immediate priority is patient safety. A respiratory rate of 8 is incompatible with adequate ventilation and gas exchange, and administering another dose of a CNS depressant could lead to respiratory arrest. The medication must be held, and the provider must be notified immediately to prevent further decompensation.

Why the Other Options Are Incorrect

- Option 1: Blood pressure 150/90 mmHg. This blood pressure reading represents hypertension, an expected finding in alcohol withdrawal due to sympathetic nervous system hyperactivity. While it requires monitoring and eventual control, it is not a sign of benzodiazepine toxicity and does not warrant withholding the very medication intended to treat this symptom. The therapeutic goal of chlordiazepoxide is to stabilize vital signs, including blood pressure.

- Option 3: Mild hand tremors. Tremors are a hallmark and expected symptom of alcohol withdrawal. Their presence indicates that the patient is still experiencing withdrawal and requires continued pharmacological management with the prescribed chlordiazepoxide, not that the medication should be stopped.

- Option 4: Anxiety and restlessness. Like tremors and hypertension, anxiety and restlessness are core psychological and physical manifestations of alcohol withdrawal. These are the very symptoms the chlordiazepoxide is prescribed to alleviate. Holding the medication would worsen the patient’s withdrawal syndrome and increase the risk of progression to more severe complications like seizures or delirium tremens.

Clinical Safety and Nursing Judgment
This scenario highlights a critical safety principle in symptom-triggered benzodiazepine therapy. The nurse must distinguish between the expected symptoms of the condition being treated (alcohol withdrawal) and the adverse effects of the treatment itself. The studies underscore that the risk of respiratory depression is not merely theoretical but a documented cause of ICU admission [1,2]. Your clinical judgment must prioritize the assessment of sedation level and respiratory status over the autonomic signs of withdrawal. A patient’s respiratory drive is the most sensitive indicator of CNS depression, and a rate of 8 breaths per minute represents a failure of this vital protective mechanism, requiring an immediate halt to further CNS depressant administration.